Related Experiment Video
Updated: Sep 10, 2025

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters
Published on: July 12, 2024
Ambient PM1 on COPD mortality: insights from a population-based study
Wenfeng Lu1, Hong Sun2, Ruijun Xu3
1Institute for Chemical Carcinogenesis, Guangzhou Medical University, Guangzhou, Guangdong, China.
Background:
Evidence on the short-term association between particulate matter with an aerodynamic diameter of ≤1 µm (PM1) and mortality from chronic obstructive pulmonary disease (COPD) is scarce. We aimed to explore the potential effects of PM1 on COPD mortality.
Methods:
We conducted a province-wide time-stratified case-crossover study in 13 cities of Jiangsu province, China, from 2015 to 2019. Daily mortality data were collected and PM1 at the individual level was estimated using a gridded dataset (10 km × 10 km) linked to personal residential addresses. The effects of PM1 on COPD mortality were evaluated using conditional logistic regression. We also investigated the exposure-response relations and potential effect modifiers.
Results:
A total of 255 043 COPD deaths were included in data analyses. Each 10 μg/m3 increase in PM1 was associated with increased mortality risk of 3.32% (2.67%-3.97%) for COPD, 3.75% (2.30%-5.22%) for chronic bronchitis, 3.25% (1.09%-5.45%) for emphysema and 3.35% (2.56%-4.15%) for acute exacerbation of COPD (AECOPD), respectively. Natural cubic splines analysis revealed linear relationships for PM1 and COPD mortality. Particulate matter with an aerodynamic diameter of ≤2.5 µm (PM2.5) had slightly weaker effects on COPD mortality than PM1. Population attributable fractions for PM1-related mortality from COPD, chronic bronchitis, emphysema and AECOPD were 8.86%, 8.84%, 8.25% and 8.86%, respectively.
Conclusions:
This study provides new evidence of an association between short-term exposure to PM1 and COPD mortality. Our findings suggest a predominant role of PM1 within PM2.5 and emphasise the need for targeted strategies to reduce PM1 concentrations.
More Related Videos
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:

